DRI

Darden Restaurants

$225.74

-2.45%
Nov 20, 2026
Bobby Quantitative Model
Darden Restaurants is the largest full-service dining operator in the world, generating over $13 billion in system sales across roughly 2,200 company-owned restaurants in the U.S. and Canada, with a portfolio of ten banners spanning four segments — Olive Garden (about 42% of sales), LongHorn Steakhouse (26%), fine dining (21%, including The Capital Grille, Ruth's Chris and Eddie V's), and smaller concepts such as Yard House and Cheddar's. Its scale, vertically integrated supply chain and multi-brand breadth give it a structural cost advantage and a data-driven marketing edge that smaller casual-dining peers cannot easily replicate, positioning it as the sector's dominant consolidator rather than a niche challenger. The current investor debate centers on whether Darden can sustain positive same-store sales and margin recovery as casual dining regains share from an increasingly expensive fast-food channel, while digesting the Ruth's Chris acquisition and managing elevated capital spending on new-unit growth and remodels. Recent momentum has been strongly positive — the stock has rallied to within a few percent of its 52-week high on improving traffic trends and a favorable value-gap narrative versus quick-service peers — but valuation and a leveraged balance sheet remain the key points of contention among analysts.

People also watch

McDonald's

McDonald's

MCD

Analysis
Starbucks

Starbucks

SBUX

Analysis
Yum! Brands

Yum! Brands

YUM

Analysis
Chipotle Mexican Grill

Chipotle Mexican Grill

CMG

Analysis
Restaurant Brands International

Restaurant Brands International

QSR

Analysis

BobbyInvestment Opinion: Should I buy DRI Today?

Rating: Hold. Darden is a high-quality, cash-generative category leader, but at $228.74 it trades within 2.1% of the $233.44 average analyst target and about 2.2% below its 52-week high of $233.98, so the risk/reward at current levels is balanced rather than compelling. The core thesis is that a 3.0% dividend yield, $1.057 billion of TTM free cash flow and mid-single-digit revenue growth justify owning the business, but not chasing it after a 30.40% one-year rally that has already captured most of the consensus upside.

Supporting evidence is solid: revenue grew 5.11% year-over-year to $3.203 billion in the latest quarter, TTM free cash flow of $1.057 billion comfortably funds the 3.0% yield at a 57.4% payout ratio, and the stock trades at 19.30x trailing and 18.45x forward earnings with a 1.13 PEG — roughly mid-range in its historical 13.8x-26.1x PE band. The 13.6x EV/EBITDA and 1.75x PS are undemanding for a scale leader, and 18 of 25 analysts rate the shares Buy with a 1.86 mean rating. However, the implied upside to the average target is only +2.1%, and the $163-$276 target range spans roughly 49% of the current price, signaling genuine disagreement about the outlook.

The biggest risks that could invalidate the thesis are margin volatility — operating margin swung from 14.46% in Q4 FY26 to 9.98% in Q1 FY27 — a leveraged balance sheet at 2.87x debt-to-equity with a 0.314 current ratio, and intensifying value competition from rivals such as Chili's, which posted 8.6% same-store sales growth. This Hold would upgrade to Buy if the stock pulled back toward the $197-$200 support shelf (roughly 13-14% downside, implying about 17x forward earnings) or if same-store sales accelerated and operating margins sustainably returned to the 13-14% range; it would downgrade to Sell if traffic turned negative or margins fell below the recent 9.98% level. On balance, the stock is fairly valued relative to its own history and modestly attractive versus growth-oriented peers, but not undervalued enough to justify new money at $228.74.

Sign up to view all

DRI 12-Month Price Forecast

Darden is a high-quality compounder whose business momentum is intact — 5.11% revenue growth, $1.057 billion of TTM free cash flow and a 3.0% dividend yield at a 57.4% payout — but the stock has already re-rated 30.40% over the past year and now sits just 2.2% below its 52-week high with only 2.1% implied upside to the consensus target. Valuation at 19.30x trailing and 18.45x forward earnings is fair rather than cheap, sitting mid-range in the historical 13.8x-26.1x band, while the 0.634 beta and -15.12% max drawdown make this a comparatively low-volatility holding. The 18 Buy versus 9 Hold and 1 Sell ratings distribution is constructive, but the $163-$276 target dispersion shows analysts genuinely disagree on whether margins can recover toward the 13-14% range. I would upgrade to bullish if same-store sales accelerate and operating margin sustainably returns above 13%, or if the stock pulls back toward the $197-$200 support shelf; I would downgrade to bearish if traffic turns negative or margins fall below the 9.98% Q1 FY27 level.

Historical Price
Current Price $225.74
Average Target $235.00
High Target $276.00
Low Target $163.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Darden Restaurants's 12-month outlook, with a consensus price target around $233.44 and implied upside of +3.4% versus the current price.

Average Target

$233.44

28 analysts

Implied Upside

+3.4%

vs. current price

Analyst Count

28

covering this stock

Price Range

$163 - $276

Analyst target range

Buy
18 (64%)
Hold
9 (32%)
Sell
1 (4%)

Coverage is robust, with 25 analysts publishing ratings: 18 Buy, 9 Hold and 1 Sell, yielding a consensus recommendation of "buy" and a mean rating of 1.86 (on a 1-5 scale where 1 is Strong Buy). The average price target of $233.44 implies just +2.1% upside from the current $228.74 — a notably thin margin that suggests the stock has already caught up to consensus fair value after its 30% one-year rally. Consensus FY EPS of $14.46 and revenue of $16.38 billion underpin that target, and the bullish tilt of the ratings distribution contrasts with the modest implied upside, implying analysts see limited near-term re-rating potential.

The target range is wide — $163.00 low to $276.00 high — a spread of 113 points, or roughly 49% of the current price, signaling meaningful disagreement about the outlook. The high target of $276 (about 21% above current) likely assumes accelerating same-store sales, successful Ruth's Chris integration and margin expansion toward historical peaks; the low target of $163 (about 29% below current) prices in traffic deterioration, wage and commodity inflation, or a consumer slowdown that compresses margins. Institutional ratings activity is stable rather than directional — recent actions from Stephens & Co. (Equal Weight), Mizuho (Outperform), BTIG (Buy), Guggenheim (Buy), Citigroup (Buy), BMO (Market Perform) and TD Cowen (Hold) are all reiterations with no upgrades or downgrades, indicating conviction without fresh catalysts. The combination of a bullish consensus, thin implied upside and a wide target range argues for a hold-and-collect-the-dividend posture rather than aggressive accumulation at current levels.

Drowning in data?

Find the real signal!

Bulls vs Bears: DRI Investment Factors

The bull case rests on durable fundamentals: 5.11% revenue growth, $1.057 billion of TTM free cash flow, a 3.0% covered dividend, and a reasonable 19.3x PE with a 1.13 PEG — all delivered with a low 0.634 beta and 18.13 points of one-year relative outperformance versus SPY. The bear case is primarily about price rather than quality: only +2.1% implied upside to the $233.44 average target, a stock sitting 2.2% below its 52-week high after a 30% run, 2.87x debt-to-equity, a 0.314 current ratio, and volatile operating margins ranging from 9.98% to 14.46% across recent quarters. On balance, the evidence favors the bulls on business quality and cash generation, but the bears have the stronger argument on near-term risk/reward given the thin implied upside and wide $163-$276 target dispersion. The single most important tension is whether same-store sales and margin recovery can sustain the recent momentum — if traffic holds and margins normalize toward the 13-14% range, the stock can grind higher; if traffic deteriorates, the leveraged balance sheet and full valuation leave little room for error.

Bullish

  • Momentum leadership with low beta: DRI is up 30.40% over one year and 22.18% YTD, outperforming SPY by 18.13 and 11.56 percentage points respectively, yet does so with a beta of just 0.634. The move is stock-specific rather than market-driven, and the max drawdown of only -15.12% shows the uptrend has been orderly rather than speculative.
  • Steady mid-single-digit revenue compounding: Latest-quarter revenue of $3.203 billion grew 5.11% year-over-year, and Q4 FY26 revenue of $3.719 billion jumped 13.7% versus the prior-year Q4 of $3.272 billion, aided by Ruth's Chris integration and pricing. The sequential progression from $3.045B to $3.719B demonstrates durable, low-cyclicality top-line expansion.
  • Strong cash generation funds shareholder returns: TTM free cash flow is $1.057 billion, and the latest quarter alone produced $275.8 million of operating cash flow against $175.3 million of capex. That funded $184.2 million of dividends and $220.8 million of buybacks in a single quarter, supporting the 3.0% yield at a well-covered 57.4% payout ratio.
  • Reasonable valuation with a yield floor: At 19.30x trailing and 18.45x forward earnings with a PEG of 1.13, DRI trades near the middle of its historical 13.8x-26.1x PE band. The 13.6x EV/EBITDA and 1.75x PS are undemanding for a scale leader, and the 3.0% dividend yield provides a valuation floor that many casual-dining peers lack.

Bearish

  • Thin implied upside to consensus target: The average analyst target of $233.44 implies only +2.1% upside from $228.74, and the stock already sits about 2.2% below its 52-week high of $233.98. After a 30% one-year rally, the stock appears to have caught up to consensus fair value, limiting near-term re-rating potential.
  • Leveraged balance sheet with thin liquidity: Debt-to-equity stands at 2.87x and the current ratio is a very thin 0.314, meaning the company depends on operating cash flow rather than liquidity buffers. The 10.45x price-to-book is an artifact of this leverage and buyback activity, and it leaves limited cushion if traffic slows.
  • Volatile operating margins: Operating margin swung from 14.46% in Q4 FY26 to 13.16% in Q3 FY26, 10.50% in Q2 FY26 and 9.98% in Q1 FY27, reflecting seasonality and cost inflation. The latest quarter's 9.98% operating margin and 7.29% net margin are well below the seasonally strong Q4 levels, showing earnings sensitivity to cost pressures.
  • Wide analyst dispersion signals uncertainty: The target range spans $163 to $276 — a 113-point spread equal to roughly 49% of the current price. The $163 low target implies about 29% downside and prices in traffic deterioration or margin compression, underscoring genuine disagreement about the outlook despite the bullish consensus rating.

DRI Technical Analysis

Darden is in a sustained, well-established uptrend: the stock is up 30.40% over the past year and 22.18% year-to-date, and at $228.74 it sits at roughly 90% of its 52-week range (low $169.00, high $233.98) — about 2.2% below the high. That positioning signals momentum leadership rather than deep value; the stock is near the top of its range but not yet at an extreme breakout, leaving room before overextension becomes a concern. Relative strength confirms the trend: DRI has outperformed SPY by 18.13 percentage points over one year and 11.56 points YTD, with a beta of just 0.634 indicating the move has been driven by stock-specific fundamentals rather than market beta.

Short-term momentum is accelerating sharply and diverging positively from the longer-term trend. The stock gained 9.70% in the last month versus a 2.26% decline for SPY — a relative strength spread of 11.96 points — while the 3-month change is only 1.54% (versus SPY -2.83%), meaning most of the recent gain is fresh. That pattern — a flat-to-choppy summer followed by a powerful October-November thrust from roughly $197 on September 30 to $230.61 on November 4 — is characteristic of a breakout, not a mean-reversion bounce, and the 6-month gain of 16.77% versus SPY's 2.13% reinforces that buyers have consistently stepped in on dips. Volume data is unavailable (reported as zero), so confirmation must come from price structure alone.

Key technical levels are well defined: immediate resistance sits at the 52-week high of $233.98, roughly 2.3% above the current $228.74, and a decisive break above it would signal a new leg higher and likely draw momentum and trend-following capital. Support is anchored at the 52-week low of $169.00 (about 26% below current price), with a nearer intermediate shelf around $197-$200 formed by the late-September/early-October consolidation; a breakdown below that shelf would flag trend deterioration. With a beta of 0.634 and a maximum drawdown over the period of only -15.12%, Darden is a comparatively low-volatility vehicle — roughly 37% less volatile than the market — which supports larger position sizing for risk-parity investors but also means upside torque is more modest than high-beta peers.

Beta

0.63

0.63x market volatility

Max Drawdown

-15.1%

Largest decline past year

52-Week Range

$173-$240

Price range past year

Annual Return

+33.4%

Cumulative gain past year

PeriodDRI ReturnS&P 500
1m+5.2%-9.7%
3m+1.9%-9.9%
6m+10.9%-7.5%
1y+33.4%+4.7%
ytd+20.6%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

DRI Fundamental Analysis

Revenue is growing at a steady mid-single-digit pace: the most recent quarter (ended August 30, 2026) posted $3.203 billion in revenue, up 5.11% year-over-year from $3.045 billion, and the trailing four quarters total roughly $13.48 billion. The multi-quarter trend shows consistent sequential expansion — $3.045B, $3.102B, $3.345B, $3.719B, then $3.203B — with the Q4 fiscal 2026 quarter at $3.719 billion representing a 13.7% jump over the prior-year Q4 of $3.272 billion, aided by the Ruth's Chris integration and pricing. Segment data shows Olive Garden at $1.330 billion, LongHorn at $861 million, fine dining at $304 million and other concepts at $705 million, confirming that the two flagship brands still drive the bulk of growth while fine dining adds a higher-ticket, higher-margin layer. The trajectory supports a durable, low-cyclicality compounding story rather than a hyper-growth narrative.

Profitability is solid and improving. The latest quarter delivered net income of $233.4 million (a 7.29% net margin) on gross profit of $2.215 billion, with a reported gross margin of 69.2% (note: this reflects a presentation where cost of revenue excludes restaurant operating costs, versus the more conventional ~21.7% gross margin in the valuation dataset) and an operating margin of 9.98%. Sequentially, operating margin has been volatile — 9.98% in Q1 FY27 versus 14.46% in Q4 FY26, 13.16% in Q3 FY26 and 10.50% in Q2 FY26 — reflecting seasonality and cost inflation, but the trailing net margin of 9.13% and operating margin of 12.16% are healthy for full-service dining. EBITDA of $413.2 million in the latest quarter (12.9% margin) versus $662.2 million in the seasonally strong Q4 shows the business converts sales into cash reliably, and the 5.11% revenue growth alongside positive net income indicates margins are stable rather than compressing.

Balance sheet leverage is the main financial risk: debt-to-equity stands at 2.87x and the current ratio is a thin 0.314, meaning the company relies on operating cash flow rather than liquidity buffers. Free cash flow TTM is $1.057 billion, and the latest quarter generated $275.8 million in operating cash flow against $175.3 million of capex, while the company returned capital aggressively — $184.2 million in dividends and $220.8 million in buybacks in the quarter. ROE is exceptionally high at 54.66% (flattered by leverage and buybacks) while ROA is a more modest 7.65%, and the 3.00% dividend yield with a 57.4% payout ratio is well covered. The combination of strong FCF, high ROE and heavy shareholder returns is attractive, but the 2.87x leverage and sub-0.35 current ratio leave limited cushion if traffic slows.

Quarterly Revenue

$3.2B

2026-08

Revenue YoY Growth

+5.1%

YoY Comparison

Gross Margin

69.2%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Fine Dining Segment
LongHorn Steakhouse
Olive Garden
Other Segments

Open an Account, get $2 TSLA now!

Valuation Analysis: Is DRI Overvalued?

Because Darden is solidly profitable (net income of $233.4 million in the latest quarter and positive TTM earnings), the PE ratio is the appropriate primary metric. The stock trades at 19.30x trailing earnings and 18.45x forward earnings — a modest 4.4% compression that implies the market expects only modest EPS growth, consistent with consensus FY EPS estimates of $14.46 against a $228.74 price. The PEG ratio of 1.13 suggests the multiple is roughly in line with expected growth, neither cheap nor stretched on a growth-adjusted basis.

Relative to the broader restaurant and consumer-cyclical sector, Darden screens as a value-to-fairly-valued operator: its 19.3x trailing PE and 13.6x EV/EBITDA are reasonable for a scale leader with a 3.0% dividend yield, and its 1.75x PS ratio and 2.56x EV/Sales are undemanding versus high-growth casual-dining peers that trade at premium multiples. The 10.45x price-to-book looks elevated, but that is an artifact of leverage and buybacks rather than operational overvaluation. On balance, the discount to growth-oriented peers appears justified by Darden's mature, mid-single-digit growth profile — but the 3.0% yield and 57% payout provide a valuation floor that many peers lack.

Historically, Darden's PE has ranged from roughly 13.8x to 26.1x over the past several years, with the current 19.3x sitting near the middle of that band — above the 14.3x trough seen in mid-2024 but well below the 26.1x peak in the latest Q1 FY27 snapshot. The PS ratio of 1.75x is near the low end of its historical 5.9x-8.1x range on the same dataset basis, suggesting the market is not pricing in heroic margin expansion. Overall, valuation looks fair-to-attractive for a defensive compounder with a 3% yield, with upside contingent on sustained same-store sales and margin recovery rather than multiple re-rating.

PE

19.3x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 14x~26x

vs. Industry Avg

27.4x

Industry PE ~27.4x*

EV/EBITDA

13.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on leverage and margin volatility. Debt-to-equity of 2.87x and a current ratio of just 0.314 mean Darden relies on operating cash flow rather than liquidity buffers, leaving little cushion if traffic slows. Operating margin has been volatile — 9.98% in Q1 FY27 versus 14.46% in Q4 FY26 and 13.16% in Q3 FY26 — showing earnings sensitivity to wage and commodity inflation, while the 10.45x price-to-book is inflated by leverage and buybacks rather than operational strength. Revenue concentration adds another layer: Olive Garden at 42% of sales and LongHorn at 26% mean the two flagship brands drive roughly two-thirds of the business, so a traffic stumble at either banner would materially hit consolidated results.

Market and competitive risks are meaningful given the stock's positioning near its highs. At 19.30x trailing and 18.45x forward earnings, DRI sits mid-range in its historical 13.8x-26.1x band, so there is limited multiple-expansion cushion if growth disappoints; the 2.1% implied upside to the $233.44 average target confirms the market already prices in fair value. Competition is intensifying — recent coverage cites Chili's 8.6% same-store sales growth and a 70% three-month rally in CAKE, showing value-focused rivals gaining traction as the price gap to fast food narrows. With a beta of 0.634, DRI is only about 37% as volatile as the market, which dampens macro-driven drawdowns but also means the stock lacks high-beta torque if sector rotation favors more cyclical consumer names.

In a worst-case scenario, a consumer slowdown combines with traffic deterioration at Olive Garden and LongHorn, wage and commodity inflation compresses margins below the recent 9.98% operating level, and the leveraged balance sheet (2.87x debt-to-equity, 0.314 current ratio) limits flexibility while capex on remodels and new units continues. That chain of events would push the stock toward the analyst low target of $163, roughly 29% below the current $228.74, and toward the 52-week low of $169, about 26% below current. Historical max drawdown over the observed period was -15.12%, so a move to the low target would represent roughly double the worst decline seen in the past six months — a realistic but painful downside of -26% to -29% from current levels.

FAQ

The most severe risk is margin compression: operating margin swung from 14.46% in Q4 FY26 to 9.98% in Q1 FY27, and a sustained sub-10% level on wage and commodity inflation would break the earnings base that supports the 18.45x forward multiple. Second is balance-sheet fragility — debt-to-equity of 2.87x and a current ratio of just 0.314 mean Darden depends on operating cash flow rather than liquidity buffers, leaving little flexibility if traffic slows while $175.3 million of quarterly capex continues. Third is competitive pressure: Chili's posted 8.6% same-store sales growth and CAKE rallied 70% in three months, showing value-focused rivals gaining traction as the price gap to fast food narrows, which threatens Darden's mid-single-digit growth. Fourth is concentration and valuation risk — Olive Garden and LongHorn together drive roughly two-thirds of sales, and with the stock 2.2% below its 52-week high and only +2.1% implied upside to the $233.44 target, there is no valuation cushion if either banner stumbles.

The 12-month outlook splits into three scenarios. The base case carries 55% probability with a $225-$245 range, assuming revenue growth holds near 5.11%, operating margin stays around the 12.16% trailing level, and the stock grinds toward the $233.44 average target with the 3.0% dividend contributing most of the total return. The bull case at 25% probability targets $255-$276, requiring same-store sales acceleration at Olive Garden and LongHorn plus margin recovery toward the 13-14% range seen in Q3 and Q4 FY26, with Ruth's Chris synergies adding support. The bear case at 20% probability targets $163-$175, driven by negative same-store sales at the two flagship banners, margins falling below 9.98%, and de-rating toward the analyst low target near the $169 52-week low. The base case is most likely because it requires only the status quo — mid-single-digit growth and stable margins — rather than a re-rating catalyst.

DRI looks fairly valued rather than cheap or expensive. At 19.30x trailing and 18.45x forward earnings with a PEG of 1.13, the stock sits near the middle of its historical 13.8x-26.1x PE band — above the 14.3x trough but far below the 26.1x peak. The 13.6x EV/EBITDA and 1.75x PS are undemanding for a scale leader with a 3.0% yield, and the 10.45x price-to-book is an artifact of leverage and buybacks rather than operational overvaluation. The market is essentially paying a fair price for mature mid-single-digit growth: consensus FY EPS of $14.46 against a $228.74 price implies only modest earnings expansion, and the 2.1% implied upside to the $233.44 average target confirms the stock has caught up to consensus fair value after its 30% run. The valuation implies the market expects stable traffic and no margin recovery heroics — upside requires same-store sales acceleration or operating margin returning to the 13-14% range, not multiple re-rating.

From a pure risk/reward standpoint, DRI is a reasonable hold but a mediocre fresh buy at $228.74. The upside to the $233.44 average analyst target is only +2.1%, while the downside to the $163 analyst low target is about -29% and to the 52-week low of $169 roughly -26% — an unfavorable skew of roughly one unit of upside for every fourteen of downside. The quality side of the ledger is genuinely strong: 5.11% revenue growth, $1.057 billion of TTM free cash flow, a 3.0% dividend covered at a 57.4% payout, and 18 of 25 analysts rating the shares Buy with a 1.86 mean rating. The biggest downside risk is margin volatility — operating margin fell from 14.46% in Q4 FY26 to 9.98% in Q1 FY27 — compounded by 2.87x debt-to-equity and a 0.314 current ratio that leave little cushion. It is a good buy for income-oriented investors willing to accumulate on a pullback toward the $197-$200 support shelf (about 17x forward earnings), and a poor buy for anyone chasing the 30.40% one-year rally at current levels.

DRI is better suited to long-term holding than short-term trading. The business is a mature, mid-single-digit grower with a 0.634 beta and a -15.12% max drawdown, so it lacks the volatility and catalyst density that short-term traders need — the 9.70% one-month gain versus SPY's -2.26% decline was a breakout move, but the 3-month change of just 1.54% shows how flat the stock can be between catalysts. The 3.0% dividend yield at a 57.4% payout and $1.057 billion of TTM free cash flow reward patience, and earnings visibility is high given ten banners and roughly 2,200 company-owned restaurants. However, with the stock 2.2% below its 52-week high and only +2.1% implied upside to the $233.44 consensus target, a new long-term position entered today starts with limited near-term return. A minimum holding period of 18-24 months is appropriate — long enough to collect roughly 4.5-6% in dividends and to see whether margins normalize toward 13-14% — with new money better deployed on a pullback toward the $197-$200 support shelf.